从疫苗到疗法:需要明确的mRNA-LNP设计原则
1Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P. R. China.
Journal of medicinal chemistry
|February 23, 2026
概括
治疗性信使RNA脂质纳米颗粒 (mRNA-LNP) 需要与疫苗不同的设计. 优化脂质和分子设计等策略提高了重复治疗使用的安全性和有效性.
科学领域:
- 生物技术是生物技术.
- 制药科学 制药科学
- 药物输送系统 药物输送系统
背景情况:
- 使者RNA (mRNA) 疗法具有前景,但面临着交付挑战.
- 目前的脂质纳米粒子 (LNP) 设计在很大程度上是针对疫苗的优化.
- 治疗应用需要增强的安全性和重复剂量疗效概况.
研究的目的:
- 概述治疗性mRNA-LNP的独特设计原则.
- 确定改善免疫兼容性和安全性的策略.
- 为了提高mRNA-LNP在重复使用时的疗效.
主要方法:
- 专注于优化可离子化脂质以获得更好的性能.
- 调查聚乙烯糖醇 (PEG) 脂质的修改或替代方案.
- 采用合理的分子设计方法来制定LNP.
主要成果:
- 优化的设计可以减少毒性和意外的免疫激活.
- 策略缓解加速血液清理,使重复剂量.
- 改进的配方提高了mRNA-LNP的治疗指数.
结论:
- 治疗性mRNA-LNP需要与疫苗分开的独特设计考虑.
- 脂质优化和合理设计是克服当前局限性的关键.
- 这些进展释放了mRNA-LNP技术更广泛的治疗潜力.
相关概念视频
Leaky Scanning
5.8K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.8K
Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Nucleic Acid Structure
9.6K
The pentose sugar in DNA is deoxyribose, while in RNA the pentose sugar is ribose. The difference between the sugars is the presence of the hydroxyl group on the ribose's second carbon and a hydrogen on the deoxyribose's second carbon. The phosphate residue attaches to the hydroxyl group of the 5′ carbon of one sugar and the hydroxyl group of the 3′ carbon of the sugar of the next nucleotide, which forms a 5′ to 3′ phosphodiester linkage.
DNA Structure
DNA...
DNA Structure
DNA...
9.6K
lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Initiation of Translation
39.6K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.6K


